Patients' preferences for therapy in advanced epithelial ovarian cancer: Development, testing, and application of a bedside decision instrument

Gynecologic Oncology

Volumn 62, Issue 3, 1996, Pages 329-335

  Elit, Laurie M ^b   Levine, Mark N ^b   Gafni, Amiram ^b   Whelan, Timothy J ^b   Doig, Gordon ^b   Streiner, David L ^b   Rosen, Barry ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HAIR LOSS; HUMAN; INFECTION; INFORMED CONSENT; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL DECISION MAKING; NAUSEA; OVARY CANCER; PARESTHESIA; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; STANDARDIZATION; TREATMENT OUTCOME; VOMITING;

EID: 0030248005     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0244     Document Type: Article

References (36)

1. 1. Cassileth, B. R., Zupkis, R. V., Sutton-Smith, K., and March, V. Information and participation preferences among cancer patients, Ann. Intern. Med. 92, 832-836 (1980).
2. 2. Charles, C., Gafni, A., and Whelan, T. Shared decision-making in the medical encounter (or it takes at least two to tango), CHEPA, Working Paper Series No. 94-18, McMaster University (1994).
3. 3. Debner, R. B. Physicians in health care management: 7. The patient-physician partnership: changing roles and the desire for information, Can. Med. Assoc. J. 151(2), 171-175 (1994).
4. 4. Degner, L. F., and Russell, C. A. Preferences for treatment control among adults with cancer, Res. Nurs. Health 11, 367-374 (1988).
5. 5. Degner, L. F., and Sloan, J. A. Decision making during serious illness: What role do patients really want to play? J. Clin. Epidemiol. 45, 941-950 (1992).
6. 6. Sutherland, H. J., Llewellyn-Thomas, H. A., Lockwood, G. A., Tritchler, D. L., and Till, J. E. Cancer patients: Their desire for information and participation in treatment decisions, J. R. Soc. Med. 82, 259-262 (1989).
7. 7. Ong, L. M., de Haes, J. C., Hoos, A. M., and Lammes, F. B. Doctor-patient communication: A review of the literature, Soc. Sci. Med. 40, 903-918 (1995).
8. 8. Emanual, E. J., and Emanuel, L. L. Four models of the physician-patient relationship, J. Am. Med. Assoc. 267, 2221-2226 (1992).
9. 9. McGuire, W. P. Ovarian cancer, in Paclitaxel in cancer treatment. (W. P. McGuire and E. K. Rowinsky, Eds.), Marcel Dekker, New York (1995).
10. 10. McGuire, W. P., Hoskins, W. J., and Brady, M. F. A phase 3 trial comparing cisplatin/cytoxan (PC) and cisplatin/taxol (PT) in advanced ovarian cancer (AOC), Am. Soc. Clin. Oncol. 12, 255 (1993).
11. 11. McGuire, W. P., Hoskins, W. J., and Brady, M. F. Taxol and cisplatin (TP) improves outcome in advanced ovarian cancer as compared to cytoxan and cisplatin, Proc. Am. Soc. Clin. Oncol. 14, 771 (1995).
12. 12. Elit, L. M., Gafni, A., and Levine, M. The economic and policy implications of adopting paclitaxel (Taxol®) as first-line therapy for advanced ovarian cancer: An Ontario perspective, J. Clin. Oncol., in press (1996).
13. 13. Froberg, D. G., and Kane, R. L. Methodology for measuring health-state preferences: III. Population and context effects, J. Clin. Epidemiol. 42, 585-592 (1992).
14. 14. Tversky, A., and Kahneman, D. The framing of decision and the psychology of choice, Science 211, 453-458 (1981).
15. 15. O'Connor, A. M., Boyd, N. F., Warde, P., Stolbach, L., and Till, J. E. Eliciting preferences for alternative drug therapies in oncology: Influence of treatment outcome description, elicitation technique and treatment experience on preferences, J. Chron. Dis. 40, 811-818 (1987).
16. 16. Kahneman, D., and Tversky, A. Choices, values and frames, Am. Psychol. 39, 341-350 (1984).
17. 17. O'Connor, A. M. Effects of framing and level of probability on patients' preferences for cancer chemotherapy, J. Clin. Epidemiol. 42, 119-126 (1989).
18. 18. O'Connor, A. M., Boyd, N. F., Warde, P., Stolbach, L., and Till, J. E. Eliciting preferences for alternative cancer drug treatments: The influence of framing, medium and rater variables, Med. Decis. Making 5, 453-463 (1985).
19. 19. Siminoff, L. A. Effects of outcome framing on treatment decisions in the real world: Impact of framing on adjuvant breast cancer decisions, Med. Decis. Making 9, 262-271 (1989).
20. 20. Mazur, D. J., and Hickam, D. H. Treatment preferences of patients and physicians, Med. Decis. Making 10, 2-5 (1990).
21. 21. McNeil, B. J., Weichselbaum, R., and Pauker, S. G. Fallacy of the five year survival in lung cancer, N. Engl. J. Med. 299, 1397-1401 (1978).
22. 22. Spielberger, C. D., Gorsuch, R. L., and Lushene, R. E. State-trait anxiety inventory ("self-evaluation questionnaire"), Consulting Psychologists Press, (1970).
23. 23. Llewellyn-Thomas, H. A., Sutherland, H. J., Tibshirani, R., Ciampi, A., Till, J. E., and Boyd, N. F. Describing health states: Methodological issues in obtaining values for health states, Med. Care 22, 543-552 (1984).
24. 24. Llewellyn-Thomas, H. A., Thiel, E. C., and Clark, R. M. Patients versus surrogates: Whose opinion counts on ethics review panels? Clin. Res. 37, 501-505 (1989).
25. 25. Llewellyn-Thomas, H. A., McGreal, M. J., Thiel, E. C., Fine, S., and Erlichman, C. Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation, Soc. Sci. Med. 32, 35-42 (1991).
26. 26. Ende, J. Kazis, L., Ash, A., and Moskowitz, M. A. Measuring patients' desire for autonomy, J. Gen. Intern. Med. 4, 23-30 (1989).
27. 27. Siminoff, L. A. Doctor-patient communication about breast cancer adjuvant therapy. J. Clin. Oncol. 7, 1192-1200 (1989).
28. 28. Levine, M. N., Gafni, A., Markham, B., and MacFarlane, D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer, Ann. Intern. Med. 117, 53-58 (1992).
29. 29. Levine, M. N., and Gafni, A. Clinical decision making vs programme evaluation perspectives, Pharmaco-Economics 4, 228-231 (1993).
30. 30. Sebban, C. Design and pretesting of an instrument to help patients with chronic myeloid leukaemia choose between allogenic bone marrow transplantation or standard chemotherapy, M. S. Thesis, McMaster University (1991).
31. 31. Sebban, C., Browman, G., Gafni, A., Norman, G., Levine, M., Assouline, D., and Fiere, D. Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia, Am. J. Hematol. 48, 221-227 (1995).
32. 32. Whelan, T. J. Development and pretesting of a decision instrument to elicit a patient's preference for adjuvant radiation post-lumpectomy for breast cancer, M. S. McMaster University (1993).
33. 33. Whelan, T. J., Levine, M, N., Gafni, A., Lukka, H., Mohide, E. A., Patel, M., and Streiner, D. L. Breast irradiation post-lumpectomy: Development and evaluation of a decision instrument, J. Clin. Oncol. (1994).
34. 34. Taylor, K. M. Telling bad news: Physicians and the disclosure of undesirable information, Sociol. Health Illness 10, 109-132 (1988).
35. 35. Brock, D. W., and Wartman, S. A. When competent patients make irrational choices, N. Engl. J. Med. 322, 1595-1599 (1990).
36. 36. Gafni, A. When does a competent patient make an irrational choice, N. Engl. J. Med. 323, 1354 (1990).